B BRENUS PHARMA
LIVE

Serial Number

79296944

Owner

BRENUS PHARMA

Attorney

Adam Weiss

Filing Date

Aug 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

B BRENUS PHARMA Trademark

Serial Number: 79296944 • Registration: 6564692

B BRENUS PHARMA is a trademark filed by BRENUS PHARMA on August 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BRENUS PHARMA (4 trademarks)

4 Rue Eric de Cromière

Entity Type: 99

Trademark Details

Filing Date

August 25, 2020

Registration Date

November 23, 2021

Published for Opposition

September 7, 2021

Goods & Services

Pharmaceutical products for treating pathologies that are controllable or curable by stimulated immunological reaction from a patient, namely, through infectious or oncological diseases; Veterinary products, namely, veterinary preparations for treating pathologies that are controllable or curable by stimulated immunological reaction from an animal, namely, through infectious or oncological diseases; Chemical preparations for pharmaceutical purposes, namely, for treating pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Biological preparations for medical or therapeutic purposes, namely, preparations for the treatment of pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Biological preparations for veterinary purposes, namely, preparations for the treatment of pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Pharmaceutical preparations, namely, immune system aids for use in human medicine; Diagnostic preparations for medical use; Diagnostic preparations for veterinary use; Immunostimulants under the pharmaceutical monopoly; medicines in the nature of vaccinal administrations for stimulating the immune system for use in human medicine; Serums under the pharmaceutical monopoly for medical purposes, namely, pharmaceutical serums for the treatment of the immune system; Biocellular preparations for therapeutic or medical purposes, namely, pharmaceutical preparations for the treatment of the immune system

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jul 24, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 6, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 12, 2022 FICS
FINAL DISPOSITION PROCESSED
May 11, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 23, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 23, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Sep 11, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 7, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 23, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 18, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 3, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 3, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 4, 2021 TROA
REFUSAL PROCESSED BY IB
Jan 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 9, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 9, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 24, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 23, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 3, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2020 REPR